Endogenous small RNA pathways can induce transcriptional gene silencing in C. elegans. piRNAs bound to the PRG-1 PIWI protein recognise their target by sequence complementarity and lead to the recruitment of RNA-dependent RNA polymerases (RdRPs). RdRPs, in turn, generate secondary siRNAs that are antisense to the target RNA and are 22 nt long with a 5' G (22G-RNAs). Other endogenous small RNA pathways such as the 26G-RNA pathway use similar amplification steps leading to 22G-RNA synthesis. In the C. elegans germline, the amplified 22G-RNAs are loaded into the argonaute protein HRDE-1 which localises to the nucleus initiating the nuclear RNAi pathway. The nuclear RNAi pathway leads to the transcriptional silencing of target genes and requires multiple chromatin factors. Silenced genes accumulate the repressive chromatin mark H3K9me3 and, remarkably, silencing of genes can last for several generations (1-6). The majority of the data linking small RNA mediated transcriptional and heritable silencing is based on evidence from genetic experiments. In order to better understand the mechanism of transcriptional and heritable silencing, it is essential to understand how key proteins in this silencing pathway function. We identified the intron binding protein EMB-4/AQR as an interaction partner of HRDE-1 in our immunoprecipitation experiments coupled to SILAC (7) based quantitative proteomics. Similar to
hrde-1,
emb-4/AQR is required for piRNA-mediated transgene silencing and the recently described 22G-RNA spreading (8) is inhibited in
emb-4/AQR mutant animals. RNA-seq experiments revealed that
emb-4/AQR is required for the repression of a subset of piRNA targets including transposable elements. In addition, some transposable elements which are de-silenced in
emb-4/AQR mutants are not targeted by the piRNA pathway, indicating a more global role for
emb-4/AQR in transposable element regulation. We are currently elucidating the molecular mechanism by which
emb-4/AQR communicates with the nuclear RNAi machinery. 1. Ashe A et al. Cell. 150(1):88. (2012) 2. Buckley BA et al. Nature. 489(7416):447. (2012) 3. Luteijn MJ et al. EMBO J. 31(16):3422. (2012) 4. Shirayama M et al. Cell. 150(1):65. (2012) 5. Rechavi O et al. Cell. 158(2):277. (2014) 6. Han T et al. Proc Natl Acad Sci USA. 106(44):18674. (2009) 7. Larance M et al. Nat Meth. 8(10):849. (2011) 8. Sapetschnig A et al., PLoS Genet. 11(3):
e1005078. (2015).